Myriad Commercially Launches Precise MRD with Select Community Oncologists
Go back to Myriad Commercially Launches Precise MRD with Select Community Oncologists| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.05 -0.3 (6.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.35 | 52 Week High | $45.34 | |||
| Open | $4.35 | 52 Week Low | $15.92 | |||
| Day High | $4.35 | P/E | 1.74 | |||
| Day Low | $3.99 | EPS | $2.33 | |||
| Volume | 798,549 | |||||



